Norway should exclude J&J, AstraZeneca from Covid vaccination scheme, says commission

Authorities on March 11 suspended the AstraZeneca rollout after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets. — Reuters pic
Authorities on March 11 suspended the AstraZeneca rollout after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets. — Reuters pic

Follow us on Instagram and subscribe to our Telegram channel for the latest updates.


OSLO, May 10 — Norway should exclude the Covid-19 vaccines made by AstraZeneca and Johnson & Johnson in its inoculation program due to a risk of rare but harmful side-effects, a government-appointed commission said today.

Those who would volunteer to take either of the two vaccines should however be allowed to do so, the commission added.

Authorities on March 11 suspended the AstraZeneca rollout after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets, some of whom later died.

On April 15, the Norwegian Institute of Public Health said the AstraZeneca vaccine should be dropped entirely but the government instead sought further advice, including on the jabs made by J&J which the country has yet to adopt. — Reuters

Related Articles